Primary Job Title Founder, President & CEO Primary Organization Cotinga Pharmaceuticals
Location London, Ontario, Canada Regions Great Lakes Gender Male
Dr. Wayne Danter is the President, Chief Executive Officer and a Director. Previously, he held the position of Chief Scientific Officer at COTI. Dr. Danter is the inventor of the CHEMSAS® process and one of the founders of COTI. He trained at the University of Western Ontario in Internal Medicine and Clinical Pharmacology. Prior to founding COTI,
Dr. Danter was an Associate Professor of Medicine at the University of Western Ontario. His clinical focus, in addition to his teaching role, at the University was in General Cardiology, Cardiovascular Diseases associated with HIV a1d Cardiovascular Risk Management.
Dr. Danter's initial research focused on the medical application of Artificial Intelligence (AI) technologies to disease diagnosis and outcome prediction. The primary aspect of his research has focused on developing Hybrid AI models to pattern the relationship between molecular strudzure and biological activity. This research has resulted in a sophisticated process for decomposing complex molecules into critical elements that permit accurate molecular structure activity modeling (CHEMSAS). His research has been published in peer-reviewed publications and he has presented at numerous international meetings. Dr. Danter is a pioneer in the evolving interface between AI Technologies and pharmacotherapeutics. These AI technologies are anticipated to play a major role in 21st century drug development.
